Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy Type 2”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT06251063
What this trial is testing

Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Boston Children's Hospital 25
Large-scale testing (Phase 3)Looking for participantsNCT07502443
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 176
Not applicableLooking for participantsNCT05773872
What this trial is testing

Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia

Who this might be right for
NarcolepsySocial Cognition
Centre Hospitalier Universitaire, Amiens 75
Large-scale testing (Phase 3)Looking for participantsNCT07598708
What this trial is testing

Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited 222
Testing effectiveness (Phase 2)Study completedNCT03772314
What this trial is testing

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Emory University 44
Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Large-scale testing (Phase 3)Looking for participantsNCT07625280
What this trial is testing

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

Who this might be right for
NarcolepsyIdiopathic Hypersomnia
Jazz Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Early research (Phase 1)Ended earlyNCT06179407
What this trial is testing

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Who this might be right for
Narcolepsy
Merck Sharp & Dohme LLC 9
Not applicableNot Yet RecruitingNCT06786377
What this trial is testing

Genetic and Clinical Characterization of Type 1 and 2 Narcolepsy in Adult and Pediatric Black and North African Populations

Who this might be right for
Narcolepsy
Assistance Publique - Hôpitaux de Paris 200
Large-scale testing (Phase 3)Looking for participantsNCT06767683
What this trial is testing

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Alkermes, Inc. 256
Large-scale testing (Phase 3)Looking for participantsNCT07646678
What this trial is testing

TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

Who this might be right for
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Takeda 500
Testing effectiveness (Phase 2)Study completedNCT05687916
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Takeda 71
Not applicableStudy completedNCT05709873
What this trial is testing

Narcolepsy Nightmare Study

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+2 more
Northwestern University 7
Not applicableActive Not RecruitingNCT07299097
What this trial is testing

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Takeda 402
Testing effectiveness (Phase 2)Study completedNCT02512588
What this trial is testing

Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Balance Therapeutics 120
Testing effectiveness (Phase 2)Study completedNCT06555783
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT07493265
What this trial is testing

Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Who this might be right for
Narcolepsy
Eisai Inc. 64
Testing effectiveness (Phase 2)Looking for participantsNCT06752668
What this trial is testing

ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited 248
Post-approval studies (Phase 4)Study completedNCT05869773
What this trial is testing

A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

Who this might be right for
Narcolepsy
Jazz Pharmaceuticals 155
Next Page